Kodiak Sciences, Inc. (KOD)
99.18
+4.92
(+5.22%)
USD |
NASDAQ |
Oct 09, 13:59
Kodiak Sciences EPS Diluted (Quarterly) : -1.048 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.048 |
| March 31, 2026 | -0.9402 |
| December 31, 2025 | -1.042 |
| September 30, 2025 | -1.163 |
| June 30, 2025 | -1.029 |
| March 31, 2025 | -1.089 |
| December 31, 2024 | -0.8377 |
| September 30, 2024 | -0.8352 |
| June 30, 2024 | -0.8585 |
| March 31, 2024 | -0.8196 |
| December 31, 2023 | -1.134 |
| September 30, 2023 | -0.9533 |
| June 30, 2023 | -1.531 |
| March 31, 2023 | -1.352 |
| December 31, 2022 | -1.347 |
| September 30, 2022 | -1.473 |
| June 30, 2022 | -1.736 |
| March 31, 2022 | -1.834 |
| Date | Value |
|---|---|
| December 31, 2021 | -1.792 |
| September 30, 2021 | -1.302 |
| June 30, 2021 | -1.083 |
| March 31, 2021 | -0.9782 |
| December 31, 2020 | -0.9698 |
| September 30, 2020 | -0.8006 |
| June 30, 2020 | -0.5781 |
| March 31, 2020 | -0.5442 |
| December 31, 2019 | -0.3951 |
| September 30, 2019 | -0.3316 |
| June 30, 2019 | -0.3053 |
| March 31, 2019 | -0.2144 |
| December 31, 2018 | -0.3981 |
| September 30, 2018 | -0.2838 |
| March 31, 2018 | -0.2422 |
| December 31, 2017 | -0.3151 |
| September 30, 2017 | -0.1244 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 12.23 |
| AbbVie, Inc. | 2.033 |
| Mirum Pharmaceuticals, Inc. | -1.061 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -65.64M |
| Total Expenses (Quarterly) | 65.64M |
| Enterprise Value | 5.949B |
| Earnings Yield | -4.23% |
| Normalized Earnings Yield | -4.228 |